scispace - formally typeset
H

Hyeryun Choe

Researcher at Scripps Research Institute

Publications -  112
Citations -  26496

Hyeryun Choe is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Chemokine receptor & Coronavirus. The author has an hindex of 60, co-authored 110 publications receiving 23477 citations. Previous affiliations of Hyeryun Choe include Brigham and Women's Hospital & Pennsylvania State University.

Papers
More filters
Journal ArticleDOI

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

TL;DR: It is found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells, indicating that ACE2 is a functional receptor for SARS-CoV.
Journal ArticleDOI

The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates

TL;DR: The ability of various members of the chemokine receptor family to support the early stages of HIV-1 infection helps to explain viral tropism and beta-chemokine inhibition of primary HIV- 1 isolates.
Journal ArticleDOI

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.

TL;DR: Testing of potential receptors demonstrated that SDF-1 signalled through, and hence 'adopted', the orphan receptor LESTR, which is therefore designated CXC-chemokine receptor-4 (CXCR-4).
Journal ArticleDOI

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5

TL;DR: It is suggested that HIV-1 attachment to CD4 creates a high-affinity binding site for CCR-5, leading to membrane fusion and virus entry.
Journal ArticleDOI

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

TL;DR: The CCR3 ligand, eotaxin, and an anti-CCR3 antibody inhibited HIV-1 infection of microglia, as did MIP-1β, which is a CCR5 ligand that promotes efficient infection of the CNS by HIV- 1.